arrow
K

Kathryn Blake

university of michigan system
H指数:36
被引数:4,574

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rationale and design for a pragmatic randomized trial to assess gene-based prescribing for SSRIs in the treatment of depression

一项实用的随机试验的原理和设计,以评估基于基因的ssri处方治疗抑郁症

2024-06-111
OAAI
Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent Asthma
2024-04-017
PRE
Early Administration of Steroids in the Ambulance Setting: An Observational Design Trial (EASI-AS-ODT)

在救护车环境中早期使用类固醇: 一项观察性设计试验 (easi-as-odt)

2023-10-193
PRE
A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma
2023-02-159
OA
Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators

代表IGNITE采用PGx研究人员进行务实的临床试验,以定制用于急性疼痛的阿片类药物

2022-08-0412
OAAI
Biomarkers to Predict Response to Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists in Adolescents and Adults with Mild Persistent Asthma
2022-03-017
OA
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy
2021-09-2518
OA
Ensuring Access to Albuterol in Schools: From Policy to Implementation An Official ATS/AANMA/ALA/NASN Policy Statement
2021-09-0118
OAAI
Geography, generalisability, and susceptibility in clinical trials
2021-04-0110
OAAI
Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems

在11个美国卫生系统的成年患者中进行基因型指导处方的机会

2021-02-1632
OAAI
2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group
2020-12-01484
OAAI
Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST)

2型气道炎症的生物标志物作为控制良好的疾病的降压治疗期间哮喘控制丧失的预测因子: 长效 β 受体激动剂降压研究 (LASST)

2020-11-018
OAAI